| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 539 | 2.306 | 4.935 | 3.853 | 16.304 | 46.438 |
| Total Income - EUR | - | - | - | - | 539 | 11.403 | 6.754 | 5.779 | 16.304 | 46.449 |
| Total Expenses - EUR | - | - | - | - | 2.525 | 8.837 | 5.002 | 5.546 | 14.062 | 41.897 |
| Gross Profit/Loss - EUR | - | - | - | - | -1.986 | 2.566 | 1.752 | 233 | 2.242 | 4.552 |
| Net Profit/Loss - EUR | - | - | - | - | -2.002 | 2.427 | 1.549 | 44 | 2.238 | 3.117 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Schiessermed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 31.836 | 28.100 | 23.814 | 19.996 | 16.378 | 92.952 |
| Current Assets | - | - | - | - | 122 | 6 | 26 | 84 | 32 | 8 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | - | - | - | - | 122 | 6 | 26 | 84 | 32 | 8 |
| Shareholders Funds | - | - | - | - | -1.960 | 504 | 2.042 | 2.092 | 4.324 | 7.064 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 38.427 | 27.603 | 21.797 | 17.988 | 12.085 | 85.896 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Schiessermed S.r.l.